Current Report · Items 3.01, 9.01 · 8-K

Aditxt, Inc.

ADTXOTCEQUITYCurrent

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Filed Sep 23, 2026Accepted Sep 23, 2026, 11:34 AM EDTCIK 1726711Accession 0001213900-26-102469

Company context

Aditxt, Inc. (NASDAQ: ADTX) is a public company focused on developing and commercializing health innovation platforms. Ignite Proteomics is currently a 100%-owned subsidiary of Aditxt. Through the proposed business combination, Aditxt expects to unlock value in Ignite at an implied equity value of approximately $150 million, while Ignite is expected to become an independent publicly traded company. Aditxt is expected to continue as a separate Nasdaq-listed public company, subject to continued compliance with Nasdaq listing requirements.

Current securities

ADTXOTC · EQUITY · Current

Recent company filings

Registered securities in this filing

ADITXT, INC. · 8-K · Filed 2026-09-23

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.001 per share

Symbol: ADTX
Exchange: NASDAQ
Classification: COMMON
Status: Current

Filing context

Context: AsOf2026-09-17

Dimensions: Not supplied

Accession 000121390026102469 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 3.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 3.01Item 3.01 - Notice of Delisting

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on June 23, 2026, the Nasdaq Hearings Panel notified Aditxt, Inc. (the “Company”) that it had denied the Company’s request to continue the listing of its common stock on The Nasdaq Stock Market LLC (“Nasdaq”) and that trading in the Company’s common stock would be suspended effective at the open of trading on June 25, 2026. Trading in the Company’s common stock on Nasdaq has been suspended since that time. On September 17, 2026, Nasdaq publicly announced that it will file a Form 25 with the Securities and Exchange Commission (the “SEC”) to complete the delisting of the Company’s common stock from Nasdaq. The delisting will become effective ten days after the filing of the Form 25. A copy of Nasdaq’s announcement is attached hereto as Exhibit 99.1. The Company’s common stock is currently quoted on the OTC Market.

Filed exhibits (1)

EX-99.1 (by filename) ea030577601ex99-1.htm

Exhibit 99.1 Delisting of Securities of Aditxt, Inc. from The Nasdaq Stock Market NEW YORK, September 17, 2026 - The Nasdaq Stock Market announced today that it will delist the common stock of Aditxt, Inc. Aditxt, Inc.’s common stock was suspended on June 25, 2026 and has not traded on Nasdaq since that time. Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting becomes effective ten days after the Form 25 is filed. For news and additional information about the company, including the basis for the delisting and whether the company’s common stock is trading on another venue, please review the company’s public filings or contact the company directly. For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series Nasdaq - Internal Use: Distribution limited to Nasdaq personnel and authorized third parties subject to confidentiality obligations

Open exhibit ↗